CTRI/2017/01/007736已完成未知
A prospective, multi-center, post markeing, randomized, controlled, single-blind, comparative study to evaluate safety and efficacy of MITSU ABâ?¢ Polyglactin 910 Suture with coated Vicrylâ?¢ Plus Antibacterial (Polyglactin 910) Suture in closure of surgical incision - MITSU ABâ?¢ Polyglactin 910 Suture
Meril EndoSurgery Pvt Ltd0 个研究点目标入组 122 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Both male and female aged >=18 years old.
- •2)Subject or a legally authorized representative must provide written Informed Consent prior to any study related procedure.
- •3)Subjects scheduled for either orthopaedic surgical procedure or gynaecological surgical procedure.
- •4)Subject agrees not to participate in any other investigational or invasive study for a period of 12 months.
- •5)Subject agrees to return for scheduled follow-up visits.
排除标准
- •1)Subject has a known allergy with triclosan.
- •2)Subject with history of HIV.
- •3)Subject in any case requiring other emergency operations.
- •4)Subject with on-going sepsis or septicaemia, on-going bacterial infections or antibiotic treatment.
研究者
相似试验
进行中（未招募）
4 期
study to evaluate safety and performance of Obturaâ?¢ Vascular Closure Device (device used for closing artery puncture site) versus manual compression (compression by using hand pressure) in the treatment of patients undergone femoral artery puncture procedure for angiography/angioplasty.CTRI/2018/01/011597Meril Life Sciences Pvt Ltd174
尚未招募
不适用
A study to evaluate the performance of a pedicle screw system for correction and fusion of Adolescent Idiopathic ScoliosisAdolescent idiopathic scoliosisMusculoskeletal - Other muscular and skeletal disordersSurgery - Other surgeryACTRN12612000316808Kspine20
招募中
不适用
Comparison of HF10 therapy combined with Conventional Medical Managment (CMM) to CMM alone in the treatment of chronic back paiISRCTN87648175evro Corp300
已完成
2 期
Clinical study on Ayurine Plus Capsules Kidney stoneCTRI/2017/12/010768Welex Laboratories Pvt Ltd62
招募中
Unknown
To evaluate the effect of Remogliflozin 100 mg or Dapagliflozin 10 mg adding to standard of care treatment for Type II Diabetes patients having chronic kidney diseaseCTRI/2023/03/050384Prof Dr Hemant Gupta